摘要
目的:观察化湿解毒扶正方联合瑞贝生治疗高危型宫颈人乳头瘤病毒感染的临床疗效。方法:按照随机数字法将130例高危型HPV感染者分为对照组和治疗组,每组各65例。对照组单纯给予瑞贝生局部用药,治疗组在对照组治疗基础上口服化湿解毒扶正方治疗,比较两组患者的临床疗效和复发率。结果:治疗后6个月内,治疗组转阴率明显高于对照组,差异有统计学意义(P<0.05);两组患者治疗后的中医证候评分均降低,但治疗组明显低于对照组,差异有统计学意义(P<0.05);治疗组有效率为87.69%,高于对照组的72.31%,差异有统计学意义(P<0.05)。结论:化湿解毒扶正方联合瑞贝生治疗宫颈HPV感染疗效显著,可改善患者临床症状和体征。
Objective To observe the clinical efficacy of Huashi Jiedu Fuzheng prescription combined with REBACIN in treatment of patients infected by high-risk human papilloma virus(HPV).Methods Totally 130 patients with high-risk HPV infection were divided into control group and observation group in accordance with the random number table.Each group has 65 cases.The control group was treated with REBACIN alone,while the observation group was treated with REBACIN combined with Huashi Jiedu Fuzheng prescription.The clinical efficacy and recurrence of the two groups were compared.Results The negative conversion rates of the observation group were significantly higher than that of the control group after treatment of 1 month,3 months and 6 months(P<0.05).The scores of TCM syndromes of the both groups decreased,but the observation group was significantly lower than that in the control group(P<0.05).The effective rate of the observation group was 87.69%,higher than that of the control group(72.31%),and the difference was statistically significant(P<0.05).Conclusion The effect of Huashi Jiedu Fuzheng prescription combined with REBACIN in the treatment of patients infected by high-risk HPV is remarkable and the clinical symptoms of the patients have improved significantly.
作者
陈卓
CHEN Zhuo(Nanyang Second General Hospital,Nanyang 473000,China)
出处
《中国民族民间医药》
2019年第17期83-85,共3页
Chinese Journal of Ethnomedicine and Ethnopharmacy
